miRNA as molecular target of polyphenols underlying their biological effects

Free Radical Biology and Medicine

Volumn 64, Issue , 2013, Pages 40-51

  Milenkovic, Dragan ^a   Jude, Baptiste ^a   Morand, Christine ^a  

^a CRNH AUVERGNE   (France)

Author keywords

MicroRNA; Nutrigenomics; Polyphenols

Indexed keywords

5 O CAFFEOYLQUINIC ACID; ANTINEOPLASTIC AGENT; CAFFEIC ACID; CATECHIN; CHLOROGENIC ACID; CURCUMIN; ELLAGITANNIN; EPIGALLOCATECHIN GALLATE; FERULIC ACID; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONOL DERIVATIVE; GENISTEIN; HESPERIDIN; ISOFLAVONE DERIVATIVE; MICRORNA; MICRORNA 1; MICRORNA 122; MICRORNA 125B; MICRORNA 155; MICRORNA 15A; MICRORNA 20A; MICRORNA 210; NARANGIN; POLYPHENOL DERIVATIVE; PROANTHOCYANIN; QUERCETIN; RESVERATROL; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOAVAILABILITY; BLADDER CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; CHEMICAL STRUCTURE; CHRONIC DISEASE; COLON CARCINOMA; DIETARY INTAKE; GENE EXPRESSION; HEART PROTECTION; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; MOLECULARLY TARGETED THERAPY; NEUROBLASTOMA CELL; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TEA; TREATMENT DURATION;

ANIMALIA;

(-)-EPIGALLOCATECHIN-3-GALLATE; 5-CQA; 5-O-CAFFEOYLQUINIC ACID; EGCG; MICRORNA; NUTRIGENOMICS; POLYPHENOLS;

ANIMALS; ANTIOXIDANTS; CURCUMIN; DIET; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; HYDROXYBENZOATES; MICRORNAS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; STILBENES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84885188985     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.05.046     Document Type: Review

References (91)

1. Slavin, J. L.; Lloyd, B. Health benefits of fruits and vegetables. Adv. Nutr. 3:506-516; 2012.
2. Perez-Jimenez, J.; Fezeu, L.; Touvier, M.; Arnault, N.; Manach, C.; Hercberg, S.; Galan, P.; Scalbert, A. Dietary intake of 337 polyphenols in French adults. Am. J. Clin. Nutr. 93:1220-1228; 2011.
3. Cassidy, A.; O'Reilly, E. J.; Kay, C.; Sampson, L.; Franz, M.; Forman, J. P.; Curhan, G.; Rimm, E. B. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr. 93:338-347; 2011.
4. Clifford, M. N.; Brown, J. E. Dietary flavonoids and health - broadening the perspective. In: Andersen, O. M., Markham, K. R., editors. Flavonoids: chemistry, biochemistry and applications. Boca Raton: CRC Press; 2006.
5. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81:230S-242S; 2005.
6. Peterson, J. J.; Dwyer, J. T.; Jacques, P. F.; McCullough, M. L. Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr. Rev. 70:491-508; 2012.
7. Mink, P. J.; Scrafford, C. G.; Barraj, L. M.; Harnack, L.; Hong, C. P.; Nettleton, J. A.; Jacobs Jr. D. R. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 85:895-909; 2007. (Pubitemid 46393524)
8. Letenneur, L.; Proust-Lima, C.; Le Gouge, A.; Dartigues, J. F.; Barberger-Gateau, P. Flavonoid intake and cognitive decline over a 10-year period. Am. J. Epidemiol. 165:1364-1371; 2007. (Pubitemid 47234313)
9. Miller, P. E.; Snyder, D. C. Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr. Clin. Pract. 27:599-612; 2012.
10. van Dam, R. M.; Naidoo, N.; Landberg, R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr. Opin. Lipidol. 24:25-33; 2013.
11. Habauzit, V.; Morand, C. Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. Ther. Adv. Chronic Dis 3:87-106; 2012.
12. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J.P.; Tognolini, M.; Borges, G.; Crozier, A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal.; 2012.
13. Williams, R. J.; Spencer, J. P. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic. Biol. Med. 52:35-45; 2012.
14. Cimino, S.; Sortino, G.; Favilla, V.; Castelli, T.; Madonia, M.; Sansalone, S.; Russo, G. I.; Morgia, G. Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid. Med. Cell Longev 2012:632959; 2012.
15. Fraga, C. G.; Galleano, M.; Verstraeten, S. V.; Oteiza, P. I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol. Aspects Med. 31:435-445; 2010.
16. Auclair, S.; Milenkovic, D.; Besson, C.; Chauvet, S.; Gueux, E.; Morand, C.; Mazur, A.; Scalbert, A. Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study. Atherosclerosis 204:e21-e27; 2009.
17. Mauray, A.; Felgines, C.; Morand, C.; Mazur, A.; Scalbert, A.; Milenkovic, D. Bilberry anthocyanin-rich extract alters expression of genes related to athero-sclerosis development in aorta of apo E-deficient mice. Nutr. Metab. Cardiovasc. Dis. 22:72-80; 2012.
18. Chanet, A.; Milenkovic, D.; Deval, C.; Potier, M.; Constans, J.; Mazur, A.; Bennetau-Pelissero, C.; Morand, C.; Berard, A. M. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in dietinduced hypercholesterolemia in mice. J. Nutr. Biochem. 23:469-477; 2012.
19. Coban, D.; Milenkovic, D.; Chanet, A.; Khallou-Laschet, J.; Sabbe, L.; Palagani, A.; Vanden Berghe, W.; Mazur, A.; Morand, C. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol. Nutr. Food Res. 56:1270-1281; 2012.
20. Milenkovic, D.; Deval, C.; Dubray, C.; Mazur, A.; Morand, C. Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLoS One 6:e26669; 2011.
21. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297; 2004.
22. Carthew, R. W.; Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655; 2009.
23. Li, L.; Xu, J.; Yang, D.; Tan, X.; Wang, H. Computational approaches for microRNA studies: a review. Mamm. Genome 21:1-12.
24. Esquela-Kerscher, A.; Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6:259-269; 2006.
25. Miska, E. A. How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev 15:563-568; 2005. (Pubitemid 41262414)
26. Wang, Y.; Lee, C. G. MicroRNA and cancer - focus on apoptosis. J. Cell. Mol. Med. 13:12-23; 2009.
27. Dyrskjot, L.; Ostenfeld, M. S.; Bramsen, J. B.; Silahtaroglu, A. N.; Lamy, P.; Ramanathan, R.; Fristrup, N.; Jensen, J. L.; Andersen, C. L; Zieger, K.; Kauppinen, S.; Ulhoi, B. P.; Kjems, J.; Borre, M.; Orntoft, T. F. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 69:4851-4860; 2009.
28. Eisenberg, I.; Alexander, M. S.; Kunkel, L. M. miRNAS in normal and diseased skeletal muscle. J. Cell. Mol. Med. 13:2-11; 2009.
29. Matkovich, S. J.; Van Booven, D. J.; Youker, K. A.; Torre-Amione, G.; Diwan, A.; Eschenbacher, W. H.; Dorn, L E.; Watson, M. A.; Margulies, K. B.; Dorn 2nd G. W. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119:1263-1271; 2009.
30. Vickers, K. C; Remaley, A. T. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr. Opin. Endocrinol. Diabetes Obes 17:150-155; 2010.
31. Bonauer, A.; Boon, R.A.; Dimmeler, S. Vascular microRNAs. Curr. Drug Targets 11:943-949.
32. Drummond, M. J.; Glynn, E. L; Fry, C. S.; Dhanani, S.; Volpi, E.; Rasmussen, B. B. Essential amino acids increase microRNA-499, -208b, and -23a and down-regulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle. J. Nutr. 139:2279-2284; 2009.
33. Davis, C. D.; Ross, S. A. Evidence for dietary regulation of microRNA expression in cancer cells. Nutr. Rev. 66:477-482; 2008.
34. Davidson, L. A.; Wang, N.; Shah, M. S.; Lupton, J. R.; Ivanov, I.; Chapkin, R. S. n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 30:2077-2084; 2009.
35. Izzotti, A.; Cartiglia, C; Steele, V. E.; De Flora, S. MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 751:287-303; 2012.
36. Kanwar, J.; Taskeen, M.; Mohammad, I.; Huo, C; Chan, T. H.; Dou, Q. P. Recent advances on tea polyphenols. Front. Biosci. (Elite Ed.) 4:111-131; 2012.
37. Widlansky, M. E.; Hamburg, N. M.; Anter, E.; Holbrook, M.; Kahn, D. F.; Elliott, J. G.; Keaney Jr. J. F.; Vita, J. A. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J. Am. Coll. Nutr. 26:95-102; 2007. (Pubitemid 46911252)
38. Zheng, X. X.; Xu, Y L; Li, S. H.; Liu, X. X.; Hui, R.; Huang, X. H. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am. J. Clin. Nutr. 94:601-610; 2011.
39. Chakrabarti, M.; Khandkar, M.; Banik, N. L.; Ray, S. K. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells. Brain Res 1454:1-13; 2012.
40. Wang, H.; Bian, S.; Yang, C. S. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 32:1881-1889; 2011.
41. Tsang, W P.; Kwok, T. T. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem. 21:140-146; 2010.
42. Long, L. H.; Hoi, A.; Halliwell, B. Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media. Arch. Biochem. Biophys. 501:162-169; 2010.
43. Siddiqui, I. A.; Asim, M.; Hafeez, B. B.; Adhami, V. M.; Tarapore, R. S.; Mukhtar, H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J 25:1198-1207; 2011.
44. Hooper, L; Kay, C; Abdelhamid, A.; Kroon, P. A.; Cohn, J. S.; Rimm, E. B.; Cassidy, A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 95:740-751; 2012.
45. Milenkovic, D.; Deval, C; Gouranton, E.; Landrier, J. F.; Scalbert, A.; Morand, C; Mazur, A. Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS One 7: e29837; 2012.
46. Russo, M.; Spagnuolo, C; Tedesco, I.; Bilotto, S.; Russo, G. L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 83:6-15; 2012.
47. Dajas, F. Life or death: neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 143:383-396; 2012.
48. Boesch-Saadatmandi, C; Loboda, A.; Wagner, A. E.; Stachurska, A.; Jozkowicz, A.; Dulak, J.; Doring, F.; Wolffram, S.; Rimbach, G. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J. Nutr. Biochem. 22:293-299; 2011.
49. Boesch-Saadatmandi, C; Wagner, A. E.; Wolffram, S.; Rimbach, G. Effect of quercetin on inflammatory gene expression in mice liver in vivo - role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacol. Res 65:523-530; 2012.
50. Lam, T. K.; Shao, S.; Zhao, Y; Marincola, F.; Pesatori, A.; Bertazzi, P. A.; Caporaso, N. E.; Wang, E.; Landi, M. T. Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol. Biomarkers Prev 21:2176-2184; 2012.
51. Chanet, A.; Milenkovic, D.; Manach, C; Mazur, A.; Morand, C. Citrus flavanones: what is their role in cardiovascular protection? J. Agric. Food Chem. 60:8809-8822; 2012.
52. Pilsakova, L; Riecansky, I.; Jagla, F. The physiological actions of isoflavone phytoestrogens. Physiol. Res. 59:651-664; 2010.
53. Li, Y.; Kong, D.; Bao, B.; Ahmad, A.; Sarkar, F. H. Induction of cancer cell death by isoflavone: the role of multiple signaling pathways. Nutrients 3:877-896; 2011.
54. Chiyomaru, T.; Yamamura, S.; Zaman, M. S.; Majid, S.; Deng, G.; Shahryari, V.; Saini, S.; Hirata, H.; Ueno, K.; Chang, I.; Tanaka, Y.; Tabatabai, Z. L.; Enokida, H.; Nakagawa, M.; Dahiya, R. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS One 7:e43812; 2012.
55. Parker, L. P.; Taylor, D. D.; Kesterson, J.; Metzinger, D. S.; Gercel-Taylor, C. Modulation of microRNA associated with ovarian cancer cells by genistein. Eur. J. Gynaecol. Oncol. 30:616-621; 2009.
56. Noratto, G. D.; Angel-Morales, G.; Talcott, S. T.; Mertens-Talcott, S. U. Polyphenolics from acai (Euterpe oleracea Mart.) and red muscadine grape (Vitis rotundifolia) protect human umbilical vascular endothelial cells (HUVEC) from glucose- and lipopolysaccharide (LPS)-induced inflammation and target microRNA-126. J. Agric. Food Chem 59:7999-8012; 2011.
57. Banerjee, N.; Talcott, S.; Safe, S.; Mertens-Talcott, S. U. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res. Treat 136:21-34; 2012.
58. Kresty, L. A.; Clarke, J.; Ezell, K.; Exum, A.; Howell, A. B.; Guettouche, T. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: insights for chemoprevention. J. Carcinog 10:34; 2011.
59. Fix, L. N.; Shah, M.; Efferth, T.; Farwell, M. A.; Zhang, B. MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60. Cancer Genomics Proteomics 7:261-277; 2010.
60. Tunca, B.; Tezcan, G.; Cecener, G.; Egeli, U.; Ak, S.; Malyer, H.; Tumen, G.; Bilir, A. Olea europaea leaf extract alters microRNA expression in human glioblastoma cells. J. Cancer Res. Clin. Oncol. 138:1831-1844; 2012.
61. Noratto, G. D.; Kim, Y.; Talcott, S. T.; Mertens-Talcott, S. U. Flavonol-rich fractions of yaupon holly leaves (Ilex vomitoria, Aquifoliaceae) induce microRNA-146a and have anti-inflammatory and chemopreventive effects in intestinal myofibroblast CCD-18Co cells. Fitoterapia 82:557-569; 2011.
62. Zhu, M.; Wang, N.; Tsao, S. W.; Yuen, M. F.; Feng, Y.; Wan, T. S.; Man, K. Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Exp. Ther. Med 2:27-32; 2011.
63. Joven, J.; Espinel, E.; Rull, A.; Aragones, G.; Rodriguez-Gallego, E.; Camps, J.; Micol, V.; Herranz-Lopez, M.; Menendez, J. A.; Borras, I.; Segura-Carretero, A.; Alonso-Villaverde, C.; Beltran-Debon, R. Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent dietinduced fatty liver disease in hyperlipidemic mice. Biochim. Biophys. Acta 1820:894-899; 2012.
64. Murase, T.; Misawa, K.; Minegishi, Y.; Aoki, M.; Ominami, H.; Suzuki, Y.; Shibuya, Y.; Hase, T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am. J. Physiol. Endocrinol. Metab. 300:E122-E133; 2011.
65. Wen, X. Y.; Wu, S. Y.; Li, Z. Q.; Liu, Z. Q.; Zhang, J. J.; Wang, G. F.; Jiang, Z. H.; Wu, S. G. Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of MiRNAs in HepG2 cancer cells. Phytother. Res. 23:778-784; 2009.
66. Esatbeyoglu, T.; Huebbe, P.; Ernst, I. M.; Chin, D.; Wagner, A. E.; Rimbach, G. Curcumin - from molecule to biological function. Angew. Chem. Int. Ed. Engl. 51:5308-5332; 2012.
67. Strimpakos, A. S.; Sharma, R. A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox Signal. 10:511-545; 2008.
68. Zhou, H.; Beevers, C. S.; Huang, S. The targets of curcumin. Curr. Drug Targets 12:332-347; 2011.
69. Gandhy, S. U.; Kim, K.; Larsen, L.; Rosengren, R. J.; Safe, S. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer 12:564; 2012.
70. Mudduluru, G.; George-William, J. N.; Muppala, S.; Asangani, I. A.; Kumarswamy, R.; Nelson, L. D.; Allgayer, H. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci. Rep. 31:185-197; 2011.
71. Saini, S.; Arora, S.; Majid, S.; Shahryari, V.; Chen, Y.; Deng, G.; Yamamura, S.; Ueno, K.; Dahiya, R. Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. (Phila.) 4:1698-1709; 2011.
72. Zhang, J.; Du, Y.; Wu, C.; Ren, X.; Ti, X.; Shi, J.; Zhao, F.; Yin, H. Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186n signaling pathway. Oncol. Rep. 24:1217-1223; 2010.
73. Gao, S. M.; Yang, J. J.; Chen, C. Q.; Chen, J. J.; Ye, L. P.; Wang, L. Y.; Wu, J. B.; Xing, C. Y.; Yu, K. Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. J. Exp. Clin. Cancer Res. 31:27; 2012.
74. Sun, M.; Estrov, Z.; Ji, Y.; Coombes, K. R.; Harris, D. H.; Kurzrock, R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther 7:464-473; 2008. (Pubitemid 351482129)
75. Yu, W.; Fu, Y. C.; Wang, W. Cellular and molecular effects of resveratrol in health and disease. J. Cell Biochem. 11 3: 752-759; 2012.
76. Li, H.; Xia, N.; Forstermann, U. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26:102-110; 2012.
77. Han, Z.; Yang, Q.; Liu, B.; Wu, J.; Li, Y.; Yang, C.; Jiang, Y. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol. Carcinogenesis 33:131-139; 2012.
78. Tili, E.; Michaille, J. J.; Adair, B.; Alder, H.; Limagne, E.; Taccioli, C.; Ferracin, M.; Delmas, D.; Latruffe, N.; Croce, C. M. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 31:1561-1566; 2010.
79. Dhar, S.; Hicks, C.; Levenson, A. S. Resveratrol and prostate cancer: promising role for microRNAs. Mol. Nutr. Food Res. 55:1219-1229; 2011.
80. Sheth, S.; Jajoo, S.; Kaur, T.; Mukherjea, D.; Sheehan, K.; Rybak, L. P.; Ramkumar, V. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PLoS One 7:e51655; 2012.
81. Tili, E.; Michaille, J. J.; Alder, H.; Volinia, S.; Delmas, D.; Latruffe, N.; Croce, C. M. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochem. Pharmacol. 80:2057-2065; 2010.
82. Mukhopadhyay, P.; Mukherjee, S.; Ahsan, K.; Bagchi, A.; Pacher, P.; Das, D. K. Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One 5:e15705; 2010.
83. Krol, J.; Loedige, I.; Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11: 597-610; 2010.
84. Breving, K.; Esquela-Kerscher, A. The complexities of microRNA regulation: mirandering around the rules. Int. J. Biochem. Cell Biol. 42:1316-1329; 2010.
85. Shehzad, A.; Lee, Y. S. Molecular mechanisms of curcumin action: signal transduction. Biofactors 39:27-36; 2013.
86. George, J.; Singh, M.; Srivastava, A. K.; Bhui, K.; Roy, P.; Chaturvedi, P. K.; Shukla, Y. Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53. PLoS One 6:e23395; 2011.
87. Gonzalez-Sarrias, A.; Espin, J. C.; Tomas-Barberan, F. A.; Garcia-Conesa, M. T. Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol. Nutr. Food Res. 53:686-698; 2009.
88. Halliwell, B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch. Biochem. Biophys 476:107-112; 2008.
89. Spencer, J. P. The impact of fruit flavonoids on memory and cognition. Br. J. Nutr. 104(Suppl. 3):S40-47; 2010.
90. Fraga, C. G.; Oteiza, P. I. Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling. Free Radic. Biol. Med. 51:813-823; 2011.
91. Kroon, P. A.; Clifford, M. N.; Crozier, A.; Day, A. J.; Donovan, J. L.; Manach, C.; Williamson, G. How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clin. Nutr. 80:15-21; 2004. (Pubitemid 41115549)